NFKB1 and B-cell chronic lymphocytic leukemia: Activation of TLR signaling has been reported in lymph node resident CLL cells (83) and in-vitro models have suggested that TLR signaling and subsequent NF-κB activation is associated with an increase in CLL proliferation and survival, and with resistance to chemotherapy (84, 85).